申请人:WisTa Laboratories Ltd.
公开号:US10399955B2
公开(公告)日:2019-09-03
Described are a compound of formula (II) or (III):
The compounds are effective in the treatment of disease, including a tauopathy condition or a disease of tau protein aggregation.
所述化合物为式 (II) 或 (III):
这些化合物可有效治疗疾病,包括牛头蛋白病症或牛头蛋白聚集症。